|
WO2020128942A1
|
|
Container with bottom resistant to opening
|
|
WO2019086408A1
|
|
Pharmaceutical compositions comprising safinamide
|
|
EP3574898A1
|
|
Safinamide for the treating myotonia
|
|
AU2017376391A1
|
|
N-acetylcysteine for use as antibacterial agent
|
|
CN109414404A
|
|
Pharmaceutical composition comprising safinamide
|
|
EP3558261A1
|
|
Pharmaceutical compositions comprising safinamide
|
|
US2020085769A1
|
|
Pharmaceutical compositions comprising safinamide
|
|
AU2017262701A1
|
|
Method, communication system and computer program for providing information indicative of concentration of allergens in the environment
|
|
EP3366284A1
|
|
Association of n-acetylcysteine and colistin for use in bacterial infections
|
|
US2017326067A1
|
|
Pharmaceutical composition containing budesonide and formoterol
|
|
ITMI20130874A1
|
|
DEGLUTIBLE TABLETS OF N-ACETYLCISTEIN
|
|
ITMI20130571A1
|
|
PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
|
|
MX2014001519A
|
|
Use of a polysaccharide polymer from the seeds of the tamarind tree in protecting against tobacco-associated damages.
|
|
AU2011340757A1
|
|
Multipurpose gel for vaginal dryness with direct and delayed effect
|
|
EP2594266A1
|
|
Pharmaceutical solid compositions containing ibuprofen salts
|
|
MY162322A
|
|
Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough
|
|
WO2008012220A1
|
|
Cosmetic or dermatological preparations comprising n-acetylcysteine
|
|
CA2669818A1
|
|
Macrolide compounds endowed with antiinflammatory activity
|
|
ITMI20061889A1
|
|
NEBIVOLOL PREPARATION PROCESS
|
|
EP1905468A1
|
|
Aerosol apparatus, in particular for children
|
